Genetic Analysis of Mammalian G-Protein Signalling

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Analysis of Mammalian G-Protein Signalling Oncogene (1998) 17, 1375 ± 1381 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc Genetic analysis of mammalian G-protein signalling Stefan Oermanns2 and Melvin I Simon1 1Division of Biology 147-75, California Institute of Technology, Pasadena, California 91125, USA; 2Institut fuÈr Pharmakologie, Freie UniversitaÈt Berlin, Thielallee 69-73, 14195 Berlin, Germany Heterotrimeric G-proteins are important signalling studies at the cellular or subcellular level, little is proteins which function in all cells of the mammalian known about their role in function and development of organism. Inactivating mutations in a variety of G- the whole organism. protein a-subunit genes in mice resulted in mostly The development of gene targeting techniques in unexpected phenotypes and have provided interesting mice has made possible the study of G-protein new insight into their biological roles. Whereas the signalling in the context of the whole organism and inactivation of some Ga genes led to mild phenotypes allows us to address questions regarding the biological suggesting the presence of redundant or compensatory function of individual G-proteins or G-protein families. mechanisms, other G-proteins appear to play highly The ®rst mutation of a G-protein a-subunit was speci®c biological or developmental roles. The purpose of published less than 3 years ago (Rudolph et al., this review is to summarize the current knowledge about 1995). Since then, the majority of the known Ga G-protein functions based on gene-inactivation studies. genes have been inactivated with mostly unexpected results (Table 1). As functional dierences between G- Keywords: G-protein; gene targeting; transgenic mouse; protein bg-complexes appear to be less pronounced, transmembrane signalling researchers have been cautious so far in targeting Gb or Gg genes. In this review, we will summarize and discuss the recent analyses of Ga mutant mice. Introduction Inactivation of Gai/o family genes The functions of individual cells in multicellular organisms are regulated and orchestrated by a vast The inactivation of the Gai2 gene was the ®rst Ga array of extracellular signals including hormones, knockout published (Rudolph et al., 1995). The growth factors, paracrine factors, neurotransmitters ubiquitously expressed G-protein a-subunit Gai2 as or sensory stimuli. Cells receive many of these signals well as its close relatives Gai1 and Gai3 have been through seven transmembrane receptors which couple implicated in the receptor-dependent inhibition of to heterotrimeric guanine nucleotide binding proteins adenylyl cyclases. Since Gi-type G-proteins are usually (G-proteins). Heterotrimeric G-proteins consist of a-, present at relatively high abundance, they also b- and g-subunits and regulate the activity of various represent an important source for bg-complexes. One eector enzymes and ion channels (Hepler and Gilman, hundred per cent of Gai2 de®cient mice bred on an 129/ 1992; Neer, 1995). G-proteins are de®ned by the Sv (inbred) background eventually develop lethal, identity of their a-subunits. So far, 16 genes encoding diuse in¯ammatory bowel disease which resembles G-protein a-subunits have been detected in mammals, in many aspects ulcerative colitis in humans. Gai2 and they appear to be involved in all aspects of de®cient mice outbred on a 129/Sv6C57BL/6 back- mammalian physiology. Some G-proteins are very ground showed greatly reduced occurrence of the specialized like those expressed speci®cally in sensory disease. Gai2 de®cient mice show increased numbers cells, others appear to have functions in a wide variety of CD4+CD87 and CD47CD8+ thymocytes with of cells and tissues. The a-subunits of mammalian G- increased staining of CD3. This altered thymocyte proteins are divided into four subfamilies based on maturation has also been described in transgenic mice homologies in sequence and function (Simon et al., speci®cally expressing the S1 subunit of pertussis toxin 1991) (Table 1). Each cell expresses multiple G- which functionally inactivates all members of the Gi- proteins, but each cell type contains a distinct set of family in thymocytes (Chan et al., 1990). However, in G-proteins. Most G-proteins couple speci®cally to addition the S1-transgenic mice show defective certain receptors and eectors, however, individual lymphocyte homing to peripheral lymphoid organs receptors and eectors can interact with more than one which was not seen in Gai2 de®cient mice. This suggests type of G-protein. Thus, some G-proteins appear to that either Gai3 or several Gi-type G-proteins, in a have overlapping distributions and functions indicating redundant fashion, mediate signalling processes in- that complex functional relationships exist among volved in T-cell homing to spleen and lymph nodes. A dierent G-proteins. While the current knowledge variety of other abnormalities were observed in Gai2 about heterotrimeric G-proteins is mainly based on de®cient mice, and in subsequent studies, dramatic changes in the phenotype and function of intestinal lymphocytes and epithelial cells have been described (HoÈ rnquist et al., 1997). On a cellular level, Gi2 may be involved in T cell activation and thymocyte matura- tion. Furthermore, receptors for most chemokines have Correspondence: MI Simon been shown to couple to Gi-type G-proteins. Thus, Genetic analysis of mammalian G-protein signalling S Offermanns and MI Simon 1376 Table 1 Mammalian G-protein a-subunits and phenotypes resulting from mutations in Ga genes Family Subtype Expression Eectors Phenotype Reference a Gas Gas ubiquitous AC (all types): embryonic lethal, parent-of-origin speci®c defects [*] in heterozygotes Gaolf olfactory epithelium AC: no mouse mutant available ± Gai/o Gai1 widely distributed no obvious phenotype seen so far [{] Gai2 ubiquitous AC (types I,V,VI); in¯ammatory bowel disease [1] Gai3 widely distributed no obvious phenotype seen so far [{] b 2+ 2+ Gao neuronal, neuroendocrine Ca -ch. (L-/N-type); CNS defects, defective Ca -ch. regulation in the [2,{] heart Gaz neuronal, platelets AC; ? viable, defective platelet activation [{] Gagust taste cells, brush cells ? impaired bitter and sweet sensation [3] Gat-r retinal rods, taste cells cGMP PDE: no mouse mutant available ± Gat-c retinal cones cGMP PDE: no mouse mutant available ± Gaq Gaq ubiquitous cerebellar ataxia, defective platelet activation [4] Ga11 almost ubiquitous PLC-b: no obvious phenotype seen so far [}] Ga14 kidney, lung, spleen (b35b144b2;b4) no obvious phenotype seen so far [$] c Ga15 hematopoietic cells no obvious phenotype seen so far [}] Ga12 Ga12 ubiquitous ? no mouse mutant available ± Ga13 ubiquitous ? defective embryonic angiogenesis (lethal) [5] a b c Four splice variants, Two splice variants, mouse form (Ga16, human counterpart). *L Weinstein (personal communication) {L Birnbaumer, M Jiang, G Boulay, K Spicher (personal communication); {IA Hendry (personal communication); }T Wilkie (personal communication); $Huiping Jiang and MIS (unpublished observation); 1Rudolph et al., 1995; 2Valenzuela et al., 1997; 3Wong et al., 1996; 4Oermanns et al., 1997b and in press; 5Oermans et al., 1997a while there are a variety of possible mechanisms have occasional seizures, which could be due to subtle whereby inactivation of the Gai2 gene may cause a alterations in the architecture of the central nervous defect in the regulation of immune responses eventually system or to some other functional defects. In addition, leading to the development of in¯ammatory bowel severely abnormal motor behaviour can be observed in disease, the exact pathogenic process is still obscure. Gao de®cient mice (L Birnbaumer, M Jiang, G Boulay, K t is also not clear to what extent a lack of the Spicher; personal communication). Severe functional biological Gai2 function can be compensated for by nervous system defects in mice lacking Gao would be other Gai subtypes (e.g. Gai1 and Gai3). Studies in predicted based on the general view that Go couples primary cells derived from Gai2 de®cient mice as well as receptors for various neurotransmitters to the inhibitory 2+ in Gai2 (7/7) embryonic stem cells suggest that regulation of neuronal Ca channels (Schultz et al., 1990; inhibitory regulation of adenylyl cyclase through Kleuss et al., 1991; Wickman and Clapham, 1995). The various receptors in the absence of Gai2 is at least neurological defects observed in Gao de®cient mice partially mediated by Gai1/Gai3 (Raymond et al., 1994; demonstrate that the lack of a high abundance signalling Rudolph et al., 1996). In embryonic stem cell derived protein does not necessarily predict that its function is cardiocytes both Gai2 and Gai3 are necessary for absolutely essential. In contrast to its abundance in the receptor mediated regulation of IK+Ach (Sowell et al., central nervous system, Gao represents only a minor 1997). In contrast to Gai2 de®cient mice, mice lacking fraction of all G-proteins in the heart. Nevertheless, it was Gai1 or Gai3 do not seem to have obvious phenotypic shown that the inhibitory muscarinic regulation of changes (L Birnbaumer, M Jiang, G Boulay, K cardiac L-type Ca2+ channels in the heart was completely Spicher; personal communication). Crosses of differ- abrogated in the Gao (7/7) mice (Valenzuela et al., ent Gai mutant mice will help to elucidate the 1997), indicating that inhibitory muscarinic regulation of functional relationships among the closely related cardiac L-type Ca2+ channels is speci®cally mediated by members of the Gai family. Go. However, since wild-type and Gao de®cient mice were The G-protein Go is expressed in neuronal and indistinguishable upon electrocardiographic analysis, the 2+ neuroendocrine cells as well as at low levels in the heart. physiological signi®cance of Go mediated Ca channel It is the most abundant G-protein in the mammalian inhibition in the heart is not clear. Certainly, the nervous system; in growth cone membranes, Go makes up inactivation of the Gao gene in mice has so far 10% of the membrane protein (Strittmatter et al., 1990).
Recommended publications
  • Genetic Variants in PLCB4/PLCB1 As Susceptibility Loci for Coronary Artery
    www.nature.com/scientificreports OPEN Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Received: 27 March 2015 Accepted: 04 September 2015 Kawasaki disease in Han Chinese Published: 05 October 2015 in Taiwan Ying-Ju Lin1,2, Jeng-Sheng Chang3,4, Xiang Liu5, Hsinyi Tsang5, Wen-Kuei Chien6, Jin-Hua Chen6,7, Hsin-Yang Hsieh3,8, Kai-Chung Hsueh9, Yi-Tzone Shiao10, Ju-Pi Li2,11, Cheng-Wen Lin12, Chih-Ho Lai13, Jer-Yuarn Wu2,14, Chien-Hsiun Chen2,14, Jaung-Geng Lin2, Ting-Hsu Lin1, Chiu-Chu Liao1, Shao-Mei Huang1, Yu-Ching Lan15, Tsung-Jung Ho2, Wen-Miin Liang16, Yi-Chun Yeh16, Jung-Chun Lin17 & Fuu-Jen Tsai1,2,18 Kawasaki disease (KD) is an acute, inflammatory, and self-limited vasculitis affecting infants and young children. Coronary artery aneurysm (CAA) formation is the major complication of KD and the leading cause of acquired cardiovascular disease among children. To identify susceptible loci that might predispose patients with KD to CAA formation, a genome-wide association screen was performed in a Taiwanese KD cohort. Patients with both KD and CAA had longer fever duration and delayed intravenous immunoglobulin treatment time. After adjusting for these factors, 100 susceptibility loci were identified. Four genes were identified from a single cluster of 35 using the Ingenuity Pathway Analysis (IPA) Knowledge Base. Silencing KCNQ5, PLCB1, PLCB4, and PLCL1 inhibited the effect of lipopolysaccharide-induced endothelial cell inflammation with varying degrees of proinflammatory cytokine expression. PLCB1 showed the most significant inhibition. Endothelial cell inflammation was also inhibited by using a phospholipase C (PLC) inhibitor.
    [Show full text]
  • Potent Lipolytic Activity of Lactoferrin in Mature Adipocytes
    Biosci. Biotechnol. Biochem., 77 (3), 566–571, 2013 Potent Lipolytic Activity of Lactoferrin in Mature Adipocytes y Tomoji ONO,1;2; Chikako FUJISAKI,1 Yasuharu ISHIHARA,1 Keiko IKOMA,1;2 Satoru MORISHITA,1;3 Michiaki MURAKOSHI,1;4 Keikichi SUGIYAMA,1;5 Hisanori KATO,3 Kazuo MIYASHITA,6 Toshihide YOSHIDA,4;7 and Hoyoku NISHINO4;5 1Research and Development Headquarters, Lion Corporation, 100 Tajima, Odawara, Kanagawa 256-0811, Japan 2Department of Supramolecular Biology, Graduate School of Nanobioscience, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan 3Food for Life, Organization for Interdisciplinary Research Projects, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan 4Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyou-ku, Kyoto 602-8566, Japan 5Research Organization of Science and Engineering, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga 525-8577, Japan 6Department of Marine Bioresources Chemistry, Faculty of Fisheries Sciences, Hokkaido University, 3-1-1 Minatocho, Hakodate, Hokkaido 041-8611, Japan 7Kyoto City Hospital, 1-2 Higashi-takada-cho, Mibu, Nakagyou-ku, Kyoto 604-8845, Japan Received October 22, 2012; Accepted November 26, 2012; Online Publication, March 7, 2013 [doi:10.1271/bbb.120817] Lactoferrin (LF) is a multifunctional glycoprotein resistance, high blood pressure, and dyslipidemia. To found in mammalian milk. We have shown in a previous prevent progression of metabolic syndrome, lifestyle clinical study that enteric-coated bovine LF tablets habits must be improved to achieve a balance between decreased visceral fat accumulation. To address the energy intake and consumption. In addition, the use of underlying mechanism, we conducted in vitro studies specific food factors as helpful supplements is attracting and revealed the anti-adipogenic action of LF in pre- increasing attention.
    [Show full text]
  • Potential Microrna Biomarkers for Acute Ischemic Stroke
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36: 1639-1647, 2015 Potential microRNA biomarkers for acute ischemic stroke YE ZENG1, JING-XIA LIU1, ZHI-PING YAN1, XING-HONG YAO2 and XIAO-HENG LIU1 1Institute of Biomedical Engineering, School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041; 2State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Sun Yat‑Sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China Received March 11, 2015; Accepted September 29, 2015 DOI: 10.3892/ijmm.2015.2367 Abstract. Acute ischemic stroke is a significant cause of high risk increases with age (6). Ischemic stroke, which accounts morbidity and mortality in the aging population globally. for 87% of all stroke subtypes presented clinically (7), is However, current therapeutic strategies for acute ischemic prevalent in populations of European origin and Chinese stroke are limited. Atherosclerotic plaque is considered an populations (5,8,9). Acute ischemic stroke is the major cause independent risk factor for acute ischemic stroke. To identify of high morbidity and mortality in the aging population world- biomarkers for carotid atheromatous plaque, bioinformatics wide (10). The prognosis is worse for stroke, with up to 50% analysis of the gene microarray data of plaque and intact tissue of the individuals worldwide confirmed to have suffered a from individuals was performed. Differentially expressed stroke succumbing or being dependent on carers 6 months genes (DEGs) were identified using the Multtest and Limma after the event (5). Current therapeutic strategies for acute packages of R language, including 56 downregulated and ischemic stroke are limited (3). Intravenous thrombolysis with 69 upregulated DEGs.
    [Show full text]
  • Protein Family Members. the GENE.FAMILY
    Table 3: Protein family members. The GENE.FAMILY col- umn shows the gene family name defined either by HGNC (superscript `H', http://www.genenames.org/cgi-bin/family_ search) or curated manually by us from Entrez IDs in the NCBI database (superscript `C' for `Custom') that we have identified as corresonding for each ENTITY.ID. The members of each gene fam- ily that are in at least one of our synaptic proteome datasets are shown in IN.SYNAPSE, whereas those not found in any datasets are in the column OUT.SYNAPSE. In some cases the intersection of two HGNC gene families are needed to specify the membership of our protein family; this is indicated by concatenation of the names with an ampersand. ENTITY.ID GENE.FAMILY IN.SYNAPSE OUT.SYNAPSE AC Adenylate cyclasesH ADCY1, ADCY2, ADCY10, ADCY4, ADCY3, ADCY5, ADCY7 ADCY6, ADCY8, ADCY9 actin ActinsH ACTA1, ACTA2, ACTB, ACTC1, ACTG1, ACTG2 ACTN ActininsH ACTN1, ACTN2, ACTN3, ACTN4 AKAP A-kinase anchoring ACBD3, AKAP1, AKAP11, AKAP14, proteinsH AKAP10, AKAP12, AKAP17A, AKAP17BP, AKAP13, AKAP2, AKAP3, AKAP4, AKAP5, AKAP6, AKAP8, CBFA2T3, AKAP7, AKAP9, RAB32 ARFGEF2, CMYA5, EZR, MAP2, MYO7A, MYRIP, NBEA, NF2, SPHKAP, SYNM, WASF1 CaM Endogenous ligands & CALM1, CALM2, EF-hand domain CALM3 containingH CaMKK calcium/calmodulin- CAMKK1, CAMKK2 dependent protein kinase kinaseC CB CalbindinC CALB1, CALB2 CK1 Casein kinase 1C CSNK1A1, CSNK1D, CSNK1E, CSNK1G1, CSNK1G2, CSNK1G3 CRHR Corticotropin releasing CRHR1, CRHR2 hormone receptorsH DAGL Diacylglycerol lipaseC DAGLA, DAGLB DGK Diacylglycerol kinasesH DGKB,
    [Show full text]
  • Convergence of Dispersed Regulatory Mutations Predicts Driver Genes in Prostate Cancer
    bioRxiv preprint doi: https://doi.org/10.1101/097451; this version posted December 30, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Convergence of dispersed regulatory mutations predicts driver genes in prostate cancer Richard C. Sallari1,2, Nicholas A. Sinnott-Armstrong3, Juliet D. French4, Ken J. Kron5,6, Jason Ho5,6, Jason H. Moore7, Vuk Stambolic5,6, Stacey L. Edwards4, Mathieu Lupien5,6,8 and Manolis Kellis1,2 1Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA. 2The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA. 3Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA. 4Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. 5The Princess Margaret Cancer Centre — University Health Network, Toronto, Ontario M5G 1L7, Canada. 6Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada. 7Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. 8Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada. Abstract Cancer sequencing predicts driver genes using recurrent protein-altering mutations, but detecting recurrence for non-coding mutations remains unsolved. Here, we present a convergence framework for
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
    Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 Inducing is online at: average * The Journal of Immunology , 11 of which you can access for free at: 2013; 191:2956-2966; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication August 2013; doi: 10.4049/jimmunol.1300376 http://www.jimmunol.org/content/191/6/2956 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol cites 49 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 This article http://www.jimmunol.org/content/191/6/2956.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 23, 2021. The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • Transcriptome Profiling Reveals the Complexity of Pirfenidone Effects in IPF
    ERJ Express. Published on August 30, 2018 as doi: 10.1183/13993003.00564-2018 Early View Original article Transcriptome profiling reveals the complexity of pirfenidone effects in IPF Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski, Malgorzata Wygrecka Please cite this article as: Kwapiszewska G, Gungl A, Wilhelm J, et al. Transcriptome profiling reveals the complexity of pirfenidone effects in IPF. Eur Respir J 2018; in press (https://doi.org/10.1183/13993003.00564-2018). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2018 Copyright 2018 by the European Respiratory Society. Transcriptome profiling reveals the complexity of pirfenidone effects in IPF Grazyna Kwapiszewska1,2, Anna Gungl2, Jochen Wilhelm3†, Leigh M. Marsh1, Helene Thekkekara Puthenparampil1, Katharina Sinn4, Miroslava Didiasova5, Walter Klepetko4, Djuro Kosanovic3, Ralph T. Schermuly3†, Lukasz Wujak5, Benjamin Weiss6, Liliana Schaefer7, Marc Schneider8†, Michael Kreuter8†, Andrea Olschewski1,
    [Show full text]
  • Stimulation of the Insulin/Mtor Pathway Delays Cone Death in a Mouse Model of Retinitis Pigmentosa
    ARTICLES Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa Claudio Punzo1, Karl Kornacker2 & Constance L Cepko1,3 Retinitis pigmentosa is an incurable retinal disease that leads to blindness. One puzzling aspect concerns the progression of the disease. Although most mutations that cause retinitis pigmentosa are in rod photoreceptor–specific genes, cone photoreceptors also die as a result of such mutations. To understand the mechanism of non-autonomous cone death, we analyzed four mouse models harboring mutations in rod-specific genes. We found changes in the insulin/mammalian target of rapamycin pathway that coincided with the activation of autophagy during the period of cone death. We increased or decreased the insulin level and measured the survival of cones in one of the models. Mice that were treated systemically with insulin had prolonged cone survival, whereas depletion of endogenous insulin had the opposite effect. These data suggest that the non-autonomous cone death in retinitis pigmentosa could, at least in part, be a result of the starvation of cones. Retinitis pigmentosa is a type of inherited retinal degeneration. It To determine the common underlying mechanism for cone death in is currently untreatable and usually leads to blindness. With over retinitis pigmentosa, we compared four mouse models harboring 40 reintitis pigmentosa genes identified, it is the most common type mutations in rod-specific genes (Pde6b–/– (ref. 11), Pde6g–/– (ref. 12), of retinal degeneration caused by a single disease allele (RetNet, Rho–/– (ref. 13) and P23H14, which carries a Rho transgene that has an http://www.sph.uth.tmc.edu/Retnet/).
    [Show full text]
  • PLCB4 Gene Phospholipase C Beta 4
    PLCB4 gene phospholipase C beta 4 Normal Function The PLCB4 gene provides instructions for making one form (the beta 4 isoform) of a protein called phospholipase C. This protein is involved in a signaling pathway within cells known as the phosphoinositide cycle, which helps transmit information from outside the cell to inside the cell. Phospholipase C carries out one particular step in the phosphoinositide cycle: the conversion of a molecule called phosphatidylinositol 4,5- bisphosphate (PIP2) to two smaller molecules, inositol 1,4,5-trisphosphate (IP3) and 1,2- diacylglycerol. These smaller molecules relay messages into the cell that ultimately influence many cell activities. Studies suggest that the beta 4 isoform of phospholipase C contributes to the development of the first and second pharyngeal arches. These embryonic structures ultimately develop into the jawbones, facial muscles, middle ear bones, ear canals, outer ears, and related tissues. This protein is also thought to play a role in vision, particularly in the function of the retina, which is a specialized tissue at the back of the eye that detects light and color. Health Conditions Related to Genetic Changes Auriculo-condylar syndrome At least nine mutations in the PLCB4 gene have been found to cause auriculo-condylar syndrome, a disorder that primarily affects the development of the ears and lower jaw ( mandible). The identified mutations change single protein building blocks (amino acids) in the the beta 4 isoform of phospholipase C. These changes likely alter the structure of the protein and impair the phosphoinositide cycle. Abnormal signaling alters the formation of the lower jaw: instead of developing normally, the lower jaw becomes shaped more like the smaller upper jaw (maxilla).
    [Show full text]
  • Supplemental Figures 04 12 2017
    Jung et al. 1 SUPPLEMENTAL FIGURES 2 3 Supplemental Figure 1. Clinical relevance of natural product methyltransferases (NPMTs) in brain disorders. (A) 4 Table summarizing characteristics of 11 NPMTs using data derived from the TCGA GBM and Rembrandt datasets for 5 relative expression levels and survival. In addition, published studies of the 11 NPMTs are summarized. (B) The 1 Jung et al. 6 expression levels of 10 NPMTs in glioblastoma versus non‐tumor brain are displayed in a heatmap, ranked by 7 significance and expression levels. *, p<0.05; **, p<0.01; ***, p<0.001. 8 2 Jung et al. 9 10 Supplemental Figure 2. Anatomical distribution of methyltransferase and metabolic signatures within 11 glioblastomas. The Ivy GAP dataset was downloaded and interrogated by histological structure for NNMT, NAMPT, 12 DNMT mRNA expression and selected gene expression signatures. The results are displayed on a heatmap. The 13 sample size of each histological region as indicated on the figure. 14 3 Jung et al. 15 16 Supplemental Figure 3. Altered expression of nicotinamide and nicotinate metabolism‐related enzymes in 17 glioblastoma. (A) Heatmap (fold change of expression) of whole 25 enzymes in the KEGG nicotinate and 18 nicotinamide metabolism gene set were analyzed in indicated glioblastoma expression datasets with Oncomine. 4 Jung et al. 19 Color bar intensity indicates percentile of fold change in glioblastoma relative to normal brain. (B) Nicotinamide and 20 nicotinate and methionine salvage pathways are displayed with the relative expression levels in glioblastoma 21 specimens in the TCGA GBM dataset indicated. 22 5 Jung et al. 23 24 Supplementary Figure 4.
    [Show full text]
  • Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model
    International Journal of Molecular Sciences Article Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model Marika Salvalaio 1,2, Francesca D’Avanzo 1,2,*, Laura Rigon 1,2, Alessandra Zanetti 1,2, Michela D’Angelo 3, Giorgio Valle 3, Maurizio Scarpa 1,2,4 and Rosella Tomanin 1,2 1 Women’s and Children’s Health Department, University of Padova, Via Giustiniani 3, 35128 Padova, Italy; [email protected] (M.S.); [email protected] (L.R.); [email protected] (A.Z.); [email protected] (M.S.); [email protected] (R.T.) 2 Pediatric Research Institute—Città della Speranza, Corso Stati Uniti 4, 35127 Padova, Italy 3 CRIBI Biotechnology Center, University of Padova, Viale G. Colombo 3, 35121 Padova, Italy; [email protected] (M.D.); [email protected] (G.V.) 4 Brains for Brain Foundation, Via Giustiniani 3, 35128 Padova, Italy * Correspondence: [email protected]; Tel.: +39-49-821-1264 Academic Editor: Ritva Tikkanen Received: 14 March 2017; Accepted: 8 May 2017; Published: 17 May 2017 Abstract: Lysosomal storage disorders (LSDs) are a group of about 50 genetic metabolic disorders, mainly affecting children, sharing the inability to degrade specific endolysosomal substrates. This results in failure of cellular functions in many organs, including brain that in most patients may go through progressive neurodegeneration. In this study, we analyzed the brain of the mouse model for Hunter syndrome, a LSD mostly presenting with neurological involvement. Whole transcriptome analysis of the cerebral cortex and midbrain/diencephalon/hippocampus areas was performed through RNA-seq.
    [Show full text]
  • Focus on Cutaneous and Uveal Melanoma Specificities
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Focus on cutaneous and uveal melanoma specificities Charlotte Pandiani, Guillaume E. Béranger, Justine Leclerc, Robert Ballotti, and Corine Bertolotto U1065, Institut National de la Santé et de la Recherche Médicale Centre Méditerranéen de Médecine Moléculaire, Université Côte d’Azur, 06200 Nice, France Cutaneous melanoma (CM) and uveal melanoma (UM) final location, where they synthesize melanin. They are derive from cutaneous and uveal melanocytes that share found in various parts of the human body, such as the the same embryonic origin and display the same cellular skin, eyes, meninges, heart, and cochlea. The role and function. However, the etiopathogenesis and biological function of melanocytes are well established in skin but behaviors of these melanomas are very different. CM not in other anatomical locations. and UM display distinct landscapes of genetic alterations In the epidermis, melanocytes transfer melanin-con- and show different metastatic routes and tropisms. Hence, taining melanosomes to neighboring keratinocytes to en- therapeutic improvements achieved in the last few years sure homogeneous pigmentation and provide efficient for the treatment of CM have failed to ameliorate the clin- skin protection against the harmful effects of ultraviolet ical outcomes of patients with UM. The scope of this radiation (UVR) from solar light (Brenner and Hearing review is to discuss the differences in tumorigenic pro- 2008). cesses (etiologic factors and genetic alterations) and tumor In the eyes, melanocytes can be found in (1) the conjunc- biology (gene expression and signaling pathways) between tiva, a nonkeratinized epithelium that covers the anterior CM and UM.
    [Show full text]